Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
209.80
+2.50 (1.21%)
At close: Mar 9, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 185.98 billion as of March 9, 2026. Its market cap has decreased by -3.54% in one year.
Market Cap
185.98B
Enterprise Value
116.02B
Revenue
81.95B
Ranking
n/a
PE Ratio
7.17
Stock Price
209.80
Market Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 185.98B, an increase of 5,894.44%. That is a compound annual growth rate of 18.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 51.21B |
| Renata | 49.23B |
| Unilever Consumer Care | 41.50B |
| Beacon Pharmaceuticals | 23.56B |
| The ACME Laboratories | 16.48B |
| The IBN SINA Pharmaceutical Industry | 9.96B |
| Asiatic Laboratories | 7.75B |
| Orion Pharma | 7.00B |